PMC:7068984 / 25270-27272 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"869","span":{"begin":691,"end":702},"obj":"Gene"},{"id":"870","span":{"begin":965,"end":978},"obj":"Gene"},{"id":"871","span":{"begin":1026,"end":1039},"obj":"Gene"},{"id":"872","span":{"begin":131,"end":136},"obj":"Species"},{"id":"873","span":{"begin":515,"end":520},"obj":"Species"},{"id":"874","span":{"begin":746,"end":751},"obj":"Species"},{"id":"875","span":{"begin":907,"end":918},"obj":"Species"},{"id":"876","span":{"begin":1122,"end":1139},"obj":"Species"},{"id":"877","span":{"begin":1366,"end":1377},"obj":"Species"},{"id":"878","span":{"begin":1659,"end":1664},"obj":"Species"},{"id":"879","span":{"begin":1678,"end":1682},"obj":"Species"},{"id":"880","span":{"begin":1966,"end":1971},"obj":"Species"},{"id":"881","span":{"begin":1979,"end":1992},"obj":"Species"},{"id":"882","span":{"begin":729,"end":738},"obj":"Species"},{"id":"883","span":{"begin":1666,"end":1675},"obj":"Species"},{"id":"884","span":{"begin":222,"end":225},"obj":"Species"},{"id":"885","span":{"begin":80,"end":99},"obj":"Chemical"},{"id":"886","span":{"begin":291,"end":302},"obj":"Chemical"},{"id":"887","span":{"begin":304,"end":318},"obj":"Chemical"},{"id":"888","span":{"begin":432,"end":442},"obj":"Chemical"},{"id":"889","span":{"begin":613,"end":619},"obj":"Chemical"},{"id":"890","span":{"begin":226,"end":230},"obj":"Disease"},{"id":"891","span":{"begin":383,"end":390},"obj":"Disease"},{"id":"892","span":{"begin":392,"end":410},"obj":"Disease"},{"id":"893","span":{"begin":1395,"end":1453},"obj":"Disease"}],"attributes":[{"id":"A869","pred":"tao:has_database_id","subj":"869","obj":"Gene:1508"},{"id":"A870","pred":"tao:has_database_id","subj":"870","obj":"Gene:4758"},{"id":"A871","pred":"tao:has_database_id","subj":"871","obj":"Gene:4758"},{"id":"A872","pred":"tao:has_database_id","subj":"872","obj":"Tax:11676"},{"id":"A873","pred":"tao:has_database_id","subj":"873","obj":"Tax:1570291"},{"id":"A874","pred":"tao:has_database_id","subj":"874","obj":"Tax:1570291"},{"id":"A875","pred":"tao:has_database_id","subj":"875","obj":"Tax:2080735"},{"id":"A876","pred":"tao:has_database_id","subj":"876","obj":"Tax:11308"},{"id":"A877","pred":"tao:has_database_id","subj":"877","obj":"Tax:39059"},{"id":"A878","pred":"tao:has_database_id","subj":"878","obj":"Tax:1570291"},{"id":"A879","pred":"tao:has_database_id","subj":"879","obj":"Tax:114727"},{"id":"A880","pred":"tao:has_database_id","subj":"880","obj":"Tax:9606"},{"id":"A881","pred":"tao:has_database_id","subj":"881","obj":"Tax:11118"},{"id":"A882","pred":"tao:has_database_id","subj":"882","obj":"Tax:11309"},{"id":"A883","pred":"tao:has_database_id","subj":"883","obj":"Tax:11309"},{"id":"A884","pred":"tao:has_database_id","subj":"884","obj":"Tax:12721"},{"id":"A885","pred":"tao:has_database_id","subj":"885","obj":"MESH:C558899"},{"id":"A886","pred":"tao:has_database_id","subj":"886","obj":"MESH:D002738"},{"id":"A888","pred":"tao:has_database_id","subj":"888","obj":"MESH:C000606551"},{"id":"A889","pred":"tao:has_database_id","subj":"889","obj":"MESH:D012694"},{"id":"A890","pred":"tao:has_database_id","subj":"890","obj":"MESH:D000163"},{"id":"A891","pred":"tao:has_database_id","subj":"891","obj":"MESH:D008288"},{"id":"A892","pred":"tao:has_database_id","subj":"892","obj":"MESH:D001327"},{"id":"A893","pred":"tao:has_database_id","subj":"893","obj":"MESH:D003586"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Status Drugs Action mode Anti-infective mechanism Target diseases Ref.\nApproved Lopinavir/Ritonavir Protease inhibitors Inhibiting HIV-1 protease for protein cleavage, resulting in non-infectious, immature viral particles HIV/AIDS, SARS, MERS [83–85]\nApproved, Investigational, Vet approved Chloroquine 9-aminoquinolin Increasing endosomal pH, immunomodulating, autophagy inhibitors Malaria, autoimmune disease [79–82]\nExperimental Remdesivir (GS-5734) Nucleotide analogue prodrug Interfering with virus post-entry Ebola, SARS, MERS\n(A wide array of RNA viruses) [76, 88, 89]\nInvestigational Nafamostat Synthetic serine protease inhibitor Prevents membrane fusion by reducing the release of cathepsin B; anticoagulant activities Influenza, MERS, Ebola [90, 91]\nApproved Ribavirin Synthetic guanosine nucleoside Interfering with the synthesis of viral mRNA (a broad-spectrum activity against several RNA and DNA viruses) HCV, SARS, MERS [92–94]\nApproved Oseltamivir Neuraminidase inhibitor Inhibiting the activity of the viral neuraminidase enzyme, preventing budding from the host cell, viral replication, and infectivity Influenza viruses A [95, 96]\nApproved Penciclovir/ Acyclovir Nucleoside analog A synthetic acyclic guanine derivative, resulting in chain termination HSV, VZV [97]\nApproved, Investigational Ganciclovir Nucleoside analog Potent inhibitor of the Herpesvirus family including cytomegalovirus AIDS-associated cytomegalovirus infections [98]\nInvestigational Favipiravir (T-705) Nucleoside analog: Viral RNA polymerase inhibitor Acting on viral genetic copying to prevent its reproduction, without affecting host cellular RNA or DNA synthesis Ebola, influenza A(H1N1) [99–101]\nApproved, Investigational, Vet approved Nitazoxanide Antiprotozoal agent Modulating the survival, growth, and proliferation of a range of extracellular and intracellular protozoa, helminths, anaerobic and microaerophilic bacteria, viruses A wide range of viruses including human/animal coronaviruses [102–104]"}

    LitCovid-PD-FMA-UBERON

    {"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T168","span":{"begin":131,"end":134},"obj":"Body_part"},{"id":"T169","span":{"begin":150,"end":157},"obj":"Body_part"},{"id":"T170","span":{"begin":222,"end":225},"obj":"Body_part"},{"id":"T171","span":{"begin":330,"end":339},"obj":"Body_part"},{"id":"T172","span":{"begin":453,"end":463},"obj":"Body_part"},{"id":"T173","span":{"begin":550,"end":553},"obj":"Body_part"},{"id":"T174","span":{"begin":613,"end":619},"obj":"Body_part"},{"id":"T175","span":{"begin":851,"end":855},"obj":"Body_part"},{"id":"T176","span":{"begin":899,"end":902},"obj":"Body_part"},{"id":"T177","span":{"begin":907,"end":910},"obj":"Body_part"},{"id":"T178","span":{"begin":1081,"end":1085},"obj":"Body_part"},{"id":"T179","span":{"begin":1221,"end":1228},"obj":"Body_part"},{"id":"T180","span":{"begin":1520,"end":1523},"obj":"Body_part"},{"id":"T181","span":{"begin":1638,"end":1641},"obj":"Body_part"},{"id":"T182","span":{"begin":1645,"end":1648},"obj":"Body_part"}],"attributes":[{"id":"A168","pred":"fma_id","subj":"T168","obj":"http://purl.org/sig/ont/fma/fma278683"},{"id":"A169","pred":"fma_id","subj":"T169","obj":"http://purl.org/sig/ont/fma/fma67257"},{"id":"A170","pred":"fma_id","subj":"T170","obj":"http://purl.org/sig/ont/fma/fma278683"},{"id":"A171","pred":"fma_id","subj":"T171","obj":"http://purl.org/sig/ont/fma/fma67180"},{"id":"A172","pred":"fma_id","subj":"T172","obj":"http://purl.org/sig/ont/fma/fma82740"},{"id":"A173","pred":"fma_id","subj":"T173","obj":"http://purl.org/sig/ont/fma/fma67095"},{"id":"A174","pred":"fma_id","subj":"T174","obj":"http://purl.org/sig/ont/fma/fma82764"},{"id":"A175","pred":"fma_id","subj":"T175","obj":"http://purl.org/sig/ont/fma/fma67122"},{"id":"A176","pred":"fma_id","subj":"T176","obj":"http://purl.org/sig/ont/fma/fma67095"},{"id":"A177","pred":"fma_id","subj":"T177","obj":"http://purl.org/sig/ont/fma/fma74412"},{"id":"A178","pred":"fma_id","subj":"T178","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A179","pred":"fma_id","subj":"T179","obj":"http://purl.org/sig/ont/fma/fma82775"},{"id":"A180","pred":"fma_id","subj":"T180","obj":"http://purl.org/sig/ont/fma/fma67095"},{"id":"A181","pred":"fma_id","subj":"T181","obj":"http://purl.org/sig/ont/fma/fma67095"},{"id":"A182","pred":"fma_id","subj":"T182","obj":"http://purl.org/sig/ont/fma/fma74412"}],"text":"Status Drugs Action mode Anti-infective mechanism Target diseases Ref.\nApproved Lopinavir/Ritonavir Protease inhibitors Inhibiting HIV-1 protease for protein cleavage, resulting in non-infectious, immature viral particles HIV/AIDS, SARS, MERS [83–85]\nApproved, Investigational, Vet approved Chloroquine 9-aminoquinolin Increasing endosomal pH, immunomodulating, autophagy inhibitors Malaria, autoimmune disease [79–82]\nExperimental Remdesivir (GS-5734) Nucleotide analogue prodrug Interfering with virus post-entry Ebola, SARS, MERS\n(A wide array of RNA viruses) [76, 88, 89]\nInvestigational Nafamostat Synthetic serine protease inhibitor Prevents membrane fusion by reducing the release of cathepsin B; anticoagulant activities Influenza, MERS, Ebola [90, 91]\nApproved Ribavirin Synthetic guanosine nucleoside Interfering with the synthesis of viral mRNA (a broad-spectrum activity against several RNA and DNA viruses) HCV, SARS, MERS [92–94]\nApproved Oseltamivir Neuraminidase inhibitor Inhibiting the activity of the viral neuraminidase enzyme, preventing budding from the host cell, viral replication, and infectivity Influenza viruses A [95, 96]\nApproved Penciclovir/ Acyclovir Nucleoside analog A synthetic acyclic guanine derivative, resulting in chain termination HSV, VZV [97]\nApproved, Investigational Ganciclovir Nucleoside analog Potent inhibitor of the Herpesvirus family including cytomegalovirus AIDS-associated cytomegalovirus infections [98]\nInvestigational Favipiravir (T-705) Nucleoside analog: Viral RNA polymerase inhibitor Acting on viral genetic copying to prevent its reproduction, without affecting host cellular RNA or DNA synthesis Ebola, influenza A(H1N1) [99–101]\nApproved, Investigational, Vet approved Nitazoxanide Antiprotozoal agent Modulating the survival, growth, and proliferation of a range of extracellular and intracellular protozoa, helminths, anaerobic and microaerophilic bacteria, viruses A wide range of viruses including human/animal coronaviruses [102–104]"}

    LitCovid-PD-MONDO

    {"project":"LitCovid-PD-MONDO","denotations":[{"id":"T179","span":{"begin":185,"end":195},"obj":"Disease"},{"id":"T180","span":{"begin":226,"end":230},"obj":"Disease"},{"id":"T181","span":{"begin":232,"end":236},"obj":"Disease"},{"id":"T182","span":{"begin":383,"end":390},"obj":"Disease"},{"id":"T183","span":{"begin":392,"end":410},"obj":"Disease"},{"id":"T184","span":{"begin":444,"end":446},"obj":"Disease"},{"id":"T185","span":{"begin":515,"end":520},"obj":"Disease"},{"id":"T186","span":{"begin":522,"end":526},"obj":"Disease"},{"id":"T187","span":{"begin":729,"end":738},"obj":"Disease"},{"id":"T188","span":{"begin":746,"end":751},"obj":"Disease"},{"id":"T189","span":{"begin":925,"end":929},"obj":"Disease"},{"id":"T190","span":{"begin":1122,"end":1131},"obj":"Disease"},{"id":"T191","span":{"begin":1411,"end":1415},"obj":"Disease"},{"id":"T192","span":{"begin":1427,"end":1453},"obj":"Disease"},{"id":"T193","span":{"begin":1659,"end":1664},"obj":"Disease"},{"id":"T194","span":{"begin":1666,"end":1683},"obj":"Disease"},{"id":"T195","span":{"begin":1666,"end":1675},"obj":"Disease"}],"attributes":[{"id":"A179","pred":"mondo_id","subj":"T179","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A180","pred":"mondo_id","subj":"T180","obj":"http://purl.obolibrary.org/obo/MONDO_0012268"},{"id":"A181","pred":"mondo_id","subj":"T181","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A182","pred":"mondo_id","subj":"T182","obj":"http://purl.obolibrary.org/obo/MONDO_0005136"},{"id":"A183","pred":"mondo_id","subj":"T183","obj":"http://purl.obolibrary.org/obo/MONDO_0007179"},{"id":"A184","pred":"mondo_id","subj":"T184","obj":"http://purl.obolibrary.org/obo/MONDO_0005773"},{"id":"A185","pred":"mondo_id","subj":"T185","obj":"http://purl.obolibrary.org/obo/MONDO_0005737"},{"id":"A186","pred":"mondo_id","subj":"T186","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A187","pred":"mondo_id","subj":"T187","obj":"http://purl.obolibrary.org/obo/MONDO_0005812"},{"id":"A188","pred":"mondo_id","subj":"T188","obj":"http://purl.obolibrary.org/obo/MONDO_0005737"},{"id":"A189","pred":"mondo_id","subj":"T189","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A190","pred":"mondo_id","subj":"T190","obj":"http://purl.obolibrary.org/obo/MONDO_0005812"},{"id":"A191","pred":"mondo_id","subj":"T191","obj":"http://purl.obolibrary.org/obo/MONDO_0012268"},{"id":"A192","pred":"mondo_id","subj":"T192","obj":"http://purl.obolibrary.org/obo/MONDO_0005132"},{"id":"A193","pred":"mondo_id","subj":"T193","obj":"http://purl.obolibrary.org/obo/MONDO_0005737"},{"id":"A194","pred":"mondo_id","subj":"T194","obj":"http://purl.obolibrary.org/obo/MONDO_0005460"},{"id":"A195","pred":"mondo_id","subj":"T195","obj":"http://purl.obolibrary.org/obo/MONDO_0005812"}],"text":"Status Drugs Action mode Anti-infective mechanism Target diseases Ref.\nApproved Lopinavir/Ritonavir Protease inhibitors Inhibiting HIV-1 protease for protein cleavage, resulting in non-infectious, immature viral particles HIV/AIDS, SARS, MERS [83–85]\nApproved, Investigational, Vet approved Chloroquine 9-aminoquinolin Increasing endosomal pH, immunomodulating, autophagy inhibitors Malaria, autoimmune disease [79–82]\nExperimental Remdesivir (GS-5734) Nucleotide analogue prodrug Interfering with virus post-entry Ebola, SARS, MERS\n(A wide array of RNA viruses) [76, 88, 89]\nInvestigational Nafamostat Synthetic serine protease inhibitor Prevents membrane fusion by reducing the release of cathepsin B; anticoagulant activities Influenza, MERS, Ebola [90, 91]\nApproved Ribavirin Synthetic guanosine nucleoside Interfering with the synthesis of viral mRNA (a broad-spectrum activity against several RNA and DNA viruses) HCV, SARS, MERS [92–94]\nApproved Oseltamivir Neuraminidase inhibitor Inhibiting the activity of the viral neuraminidase enzyme, preventing budding from the host cell, viral replication, and infectivity Influenza viruses A [95, 96]\nApproved Penciclovir/ Acyclovir Nucleoside analog A synthetic acyclic guanine derivative, resulting in chain termination HSV, VZV [97]\nApproved, Investigational Ganciclovir Nucleoside analog Potent inhibitor of the Herpesvirus family including cytomegalovirus AIDS-associated cytomegalovirus infections [98]\nInvestigational Favipiravir (T-705) Nucleoside analog: Viral RNA polymerase inhibitor Acting on viral genetic copying to prevent its reproduction, without affecting host cellular RNA or DNA synthesis Ebola, influenza A(H1N1) [99–101]\nApproved, Investigational, Vet approved Nitazoxanide Antiprotozoal agent Modulating the survival, growth, and proliferation of a range of extracellular and intracellular protozoa, helminths, anaerobic and microaerophilic bacteria, viruses A wide range of viruses including human/animal coronaviruses [102–104]"}

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T240","span":{"begin":498,"end":503},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"},{"id":"T241","span":{"begin":534,"end":535},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T242","span":{"begin":554,"end":561},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"},{"id":"T243","span":{"begin":648,"end":656},"obj":"http://purl.obolibrary.org/obo/UBERON_0000158"},{"id":"T244","span":{"begin":701,"end":702},"obj":"http://purl.obolibrary.org/obo/CLO_0001021"},{"id":"T245","span":{"begin":718,"end":728},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"},{"id":"T246","span":{"begin":857,"end":858},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T247","span":{"begin":874,"end":882},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"},{"id":"T248","span":{"begin":911,"end":918},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"},{"id":"T249","span":{"begin":940,"end":942},"obj":"http://purl.obolibrary.org/obo/CLO_0001527"},{"id":"T250","span":{"begin":1004,"end":1012},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"},{"id":"T251","span":{"begin":1081,"end":1085},"obj":"http://purl.obolibrary.org/obo/GO_0005623"},{"id":"T252","span":{"begin":1132,"end":1139},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"},{"id":"T253","span":{"begin":1140,"end":1145},"obj":"http://purl.obolibrary.org/obo/CLO_0001625"},{"id":"T254","span":{"begin":1201,"end":1202},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T255","span":{"begin":1676,"end":1677},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T256","span":{"begin":1820,"end":1821},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T257","span":{"begin":1914,"end":1922},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_2"},{"id":"T258","span":{"begin":1924,"end":1931},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"},{"id":"T259","span":{"begin":1932,"end":1933},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T260","span":{"begin":1948,"end":1955},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"},{"id":"T261","span":{"begin":1966,"end":1971},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"},{"id":"T262","span":{"begin":1972,"end":1978},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_33208"},{"id":"T263","span":{"begin":1994,"end":1997},"obj":"http://purl.obolibrary.org/obo/CLO_0054060"}],"text":"Status Drugs Action mode Anti-infective mechanism Target diseases Ref.\nApproved Lopinavir/Ritonavir Protease inhibitors Inhibiting HIV-1 protease for protein cleavage, resulting in non-infectious, immature viral particles HIV/AIDS, SARS, MERS [83–85]\nApproved, Investigational, Vet approved Chloroquine 9-aminoquinolin Increasing endosomal pH, immunomodulating, autophagy inhibitors Malaria, autoimmune disease [79–82]\nExperimental Remdesivir (GS-5734) Nucleotide analogue prodrug Interfering with virus post-entry Ebola, SARS, MERS\n(A wide array of RNA viruses) [76, 88, 89]\nInvestigational Nafamostat Synthetic serine protease inhibitor Prevents membrane fusion by reducing the release of cathepsin B; anticoagulant activities Influenza, MERS, Ebola [90, 91]\nApproved Ribavirin Synthetic guanosine nucleoside Interfering with the synthesis of viral mRNA (a broad-spectrum activity against several RNA and DNA viruses) HCV, SARS, MERS [92–94]\nApproved Oseltamivir Neuraminidase inhibitor Inhibiting the activity of the viral neuraminidase enzyme, preventing budding from the host cell, viral replication, and infectivity Influenza viruses A [95, 96]\nApproved Penciclovir/ Acyclovir Nucleoside analog A synthetic acyclic guanine derivative, resulting in chain termination HSV, VZV [97]\nApproved, Investigational Ganciclovir Nucleoside analog Potent inhibitor of the Herpesvirus family including cytomegalovirus AIDS-associated cytomegalovirus infections [98]\nInvestigational Favipiravir (T-705) Nucleoside analog: Viral RNA polymerase inhibitor Acting on viral genetic copying to prevent its reproduction, without affecting host cellular RNA or DNA synthesis Ebola, influenza A(H1N1) [99–101]\nApproved, Investigational, Vet approved Nitazoxanide Antiprotozoal agent Modulating the survival, growth, and proliferation of a range of extracellular and intracellular protozoa, helminths, anaerobic and microaerophilic bacteria, viruses A wide range of viruses including human/animal coronaviruses [102–104]"}

    LitCovid-PD-CHEBI

    {"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T178","span":{"begin":13,"end":19},"obj":"Chemical"},{"id":"T179","span":{"begin":80,"end":89},"obj":"Chemical"},{"id":"T180","span":{"begin":109,"end":119},"obj":"Chemical"},{"id":"T181","span":{"begin":150,"end":157},"obj":"Chemical"},{"id":"T182","span":{"begin":291,"end":302},"obj":"Chemical"},{"id":"T183","span":{"begin":362,"end":382},"obj":"Chemical"},{"id":"T184","span":{"begin":372,"end":382},"obj":"Chemical"},{"id":"T185","span":{"begin":444,"end":451},"obj":"Chemical"},{"id":"T186","span":{"begin":444,"end":446},"obj":"Chemical"},{"id":"T187","span":{"begin":453,"end":463},"obj":"Chemical"},{"id":"T188","span":{"begin":473,"end":480},"obj":"Chemical"},{"id":"T189","span":{"begin":613,"end":638},"obj":"Chemical"},{"id":"T190","span":{"begin":613,"end":619},"obj":"Chemical"},{"id":"T191","span":{"begin":620,"end":638},"obj":"Chemical"},{"id":"T193","span":{"begin":629,"end":638},"obj":"Chemical"},{"id":"T194","span":{"begin":704,"end":717},"obj":"Chemical"},{"id":"T195","span":{"begin":790,"end":799},"obj":"Chemical"},{"id":"T196","span":{"begin":800,"end":810},"obj":"Chemical"},{"id":"T197","span":{"begin":907,"end":910},"obj":"Chemical"},{"id":"T198","span":{"begin":953,"end":964},"obj":"Chemical"},{"id":"T199","span":{"begin":965,"end":988},"obj":"Chemical"},{"id":"T200","span":{"begin":979,"end":988},"obj":"Chemical"},{"id":"T201","span":{"begin":1183,"end":1193},"obj":"Chemical"},{"id":"T202","span":{"begin":1221,"end":1228},"obj":"Chemical"},{"id":"T203","span":{"begin":1312,"end":1323},"obj":"Chemical"},{"id":"T204","span":{"begin":1324,"end":1334},"obj":"Chemical"},{"id":"T205","span":{"begin":1349,"end":1358},"obj":"Chemical"},{"id":"T206","span":{"begin":1488,"end":1493},"obj":"Chemical"},{"id":"T207","span":{"begin":1495,"end":1505},"obj":"Chemical"},{"id":"T208","span":{"begin":1520,"end":1544},"obj":"Chemical"},{"id":"T209","span":{"begin":1535,"end":1544},"obj":"Chemical"},{"id":"T210","span":{"begin":1645,"end":1648},"obj":"Chemical"}],"attributes":[{"id":"A178","pred":"chebi_id","subj":"T178","obj":"http://purl.obolibrary.org/obo/CHEBI_5133"},{"id":"A179","pred":"chebi_id","subj":"T179","obj":"http://purl.obolibrary.org/obo/CHEBI_31781"},{"id":"A180","pred":"chebi_id","subj":"T180","obj":"http://purl.obolibrary.org/obo/CHEBI_35222"},{"id":"A181","pred":"chebi_id","subj":"T181","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"},{"id":"A182","pred":"chebi_id","subj":"T182","obj":"http://purl.obolibrary.org/obo/CHEBI_3638"},{"id":"A183","pred":"chebi_id","subj":"T183","obj":"http://purl.obolibrary.org/obo/CHEBI_88230"},{"id":"A184","pred":"chebi_id","subj":"T184","obj":"http://purl.obolibrary.org/obo/CHEBI_35222"},{"id":"A185","pred":"chebi_id","subj":"T185","obj":"http://purl.obolibrary.org/obo/CHEBI_145994"},{"id":"A186","pred":"chebi_id","subj":"T186","obj":"http://purl.obolibrary.org/obo/CHEBI_73516"},{"id":"A187","pred":"chebi_id","subj":"T187","obj":"http://purl.obolibrary.org/obo/CHEBI_36976"},{"id":"A188","pred":"chebi_id","subj":"T188","obj":"http://purl.obolibrary.org/obo/CHEBI_50266"},{"id":"A189","pred":"chebi_id","subj":"T189","obj":"http://purl.obolibrary.org/obo/CHEBI_64926"},{"id":"A190","pred":"chebi_id","subj":"T190","obj":"http://purl.obolibrary.org/obo/CHEBI_17822"},{"id":"A191","pred":"chebi_id","subj":"T191","obj":"http://purl.obolibrary.org/obo/CHEBI_37670"},{"id":"A192","pred":"chebi_id","subj":"T191","obj":"http://purl.obolibrary.org/obo/CHEBI_60258"},{"id":"A193","pred":"chebi_id","subj":"T193","obj":"http://purl.obolibrary.org/obo/CHEBI_35222"},{"id":"A194","pred":"chebi_id","subj":"T194","obj":"http://purl.obolibrary.org/obo/CHEBI_50249"},{"id":"A195","pred":"chebi_id","subj":"T195","obj":"http://purl.obolibrary.org/obo/CHEBI_16750"},{"id":"A196","pred":"chebi_id","subj":"T196","obj":"http://purl.obolibrary.org/obo/CHEBI_33838"},{"id":"A197","pred":"chebi_id","subj":"T197","obj":"http://purl.obolibrary.org/obo/CHEBI_16991"},{"id":"A198","pred":"chebi_id","subj":"T198","obj":"http://purl.obolibrary.org/obo/CHEBI_7798"},{"id":"A199","pred":"chebi_id","subj":"T199","obj":"http://purl.obolibrary.org/obo/CHEBI_52425"},{"id":"A200","pred":"chebi_id","subj":"T200","obj":"http://purl.obolibrary.org/obo/CHEBI_35222"},{"id":"A201","pred":"chebi_id","subj":"T201","obj":"http://purl.obolibrary.org/obo/CHEBI_33838"},{"id":"A202","pred":"chebi_id","subj":"T202","obj":"http://purl.obolibrary.org/obo/CHEBI_16235"},{"id":"A203","pred":"chebi_id","subj":"T203","obj":"http://purl.obolibrary.org/obo/CHEBI_465284"},{"id":"A204","pred":"chebi_id","subj":"T204","obj":"http://purl.obolibrary.org/obo/CHEBI_33838"},{"id":"A205","pred":"chebi_id","subj":"T205","obj":"http://purl.obolibrary.org/obo/CHEBI_35222"},{"id":"A206","pred":"chebi_id","subj":"T206","obj":"http://purl.obolibrary.org/obo/CHEBI_134722"},{"id":"A207","pred":"chebi_id","subj":"T207","obj":"http://purl.obolibrary.org/obo/CHEBI_33838"},{"id":"A208","pred":"chebi_id","subj":"T208","obj":"http://purl.obolibrary.org/obo/CHEBI_37416"},{"id":"A209","pred":"chebi_id","subj":"T209","obj":"http://purl.obolibrary.org/obo/CHEBI_35222"},{"id":"A210","pred":"chebi_id","subj":"T210","obj":"http://purl.obolibrary.org/obo/CHEBI_16991"}],"text":"Status Drugs Action mode Anti-infective mechanism Target diseases Ref.\nApproved Lopinavir/Ritonavir Protease inhibitors Inhibiting HIV-1 protease for protein cleavage, resulting in non-infectious, immature viral particles HIV/AIDS, SARS, MERS [83–85]\nApproved, Investigational, Vet approved Chloroquine 9-aminoquinolin Increasing endosomal pH, immunomodulating, autophagy inhibitors Malaria, autoimmune disease [79–82]\nExperimental Remdesivir (GS-5734) Nucleotide analogue prodrug Interfering with virus post-entry Ebola, SARS, MERS\n(A wide array of RNA viruses) [76, 88, 89]\nInvestigational Nafamostat Synthetic serine protease inhibitor Prevents membrane fusion by reducing the release of cathepsin B; anticoagulant activities Influenza, MERS, Ebola [90, 91]\nApproved Ribavirin Synthetic guanosine nucleoside Interfering with the synthesis of viral mRNA (a broad-spectrum activity against several RNA and DNA viruses) HCV, SARS, MERS [92–94]\nApproved Oseltamivir Neuraminidase inhibitor Inhibiting the activity of the viral neuraminidase enzyme, preventing budding from the host cell, viral replication, and infectivity Influenza viruses A [95, 96]\nApproved Penciclovir/ Acyclovir Nucleoside analog A synthetic acyclic guanine derivative, resulting in chain termination HSV, VZV [97]\nApproved, Investigational Ganciclovir Nucleoside analog Potent inhibitor of the Herpesvirus family including cytomegalovirus AIDS-associated cytomegalovirus infections [98]\nInvestigational Favipiravir (T-705) Nucleoside analog: Viral RNA polymerase inhibitor Acting on viral genetic copying to prevent its reproduction, without affecting host cellular RNA or DNA synthesis Ebola, influenza A(H1N1) [99–101]\nApproved, Investigational, Vet approved Nitazoxanide Antiprotozoal agent Modulating the survival, growth, and proliferation of a range of extracellular and intracellular protozoa, helminths, anaerobic and microaerophilic bacteria, viruses A wide range of viruses including human/animal coronaviruses [102–104]"}

    LitCovid-PD-GO-BP

    {"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T44","span":{"begin":362,"end":371},"obj":"http://purl.obolibrary.org/obo/GO_0016236"},{"id":"T45","span":{"begin":362,"end":371},"obj":"http://purl.obolibrary.org/obo/GO_0006914"},{"id":"T46","span":{"begin":648,"end":663},"obj":"http://purl.obolibrary.org/obo/GO_0061025"},{"id":"T47","span":{"begin":704,"end":728},"obj":"http://purl.obolibrary.org/obo/GO_0050819"},{"id":"T48","span":{"begin":832,"end":841},"obj":"http://purl.obolibrary.org/obo/GO_0009058"},{"id":"T49","span":{"begin":1059,"end":1066},"obj":"http://purl.obolibrary.org/obo/GO_0007114"},{"id":"T50","span":{"begin":1087,"end":1104},"obj":"http://purl.obolibrary.org/obo/GO_0019079"},{"id":"T51","span":{"begin":1087,"end":1104},"obj":"http://purl.obolibrary.org/obo/GO_0019058"},{"id":"T52","span":{"begin":1592,"end":1604},"obj":"http://purl.obolibrary.org/obo/GO_0000003"},{"id":"T53","span":{"begin":1645,"end":1658},"obj":"http://purl.obolibrary.org/obo/GO_0071897"},{"id":"T54","span":{"begin":1649,"end":1658},"obj":"http://purl.obolibrary.org/obo/GO_0009058"},{"id":"T55","span":{"begin":1791,"end":1797},"obj":"http://purl.obolibrary.org/obo/GO_0040007"}],"text":"Status Drugs Action mode Anti-infective mechanism Target diseases Ref.\nApproved Lopinavir/Ritonavir Protease inhibitors Inhibiting HIV-1 protease for protein cleavage, resulting in non-infectious, immature viral particles HIV/AIDS, SARS, MERS [83–85]\nApproved, Investigational, Vet approved Chloroquine 9-aminoquinolin Increasing endosomal pH, immunomodulating, autophagy inhibitors Malaria, autoimmune disease [79–82]\nExperimental Remdesivir (GS-5734) Nucleotide analogue prodrug Interfering with virus post-entry Ebola, SARS, MERS\n(A wide array of RNA viruses) [76, 88, 89]\nInvestigational Nafamostat Synthetic serine protease inhibitor Prevents membrane fusion by reducing the release of cathepsin B; anticoagulant activities Influenza, MERS, Ebola [90, 91]\nApproved Ribavirin Synthetic guanosine nucleoside Interfering with the synthesis of viral mRNA (a broad-spectrum activity against several RNA and DNA viruses) HCV, SARS, MERS [92–94]\nApproved Oseltamivir Neuraminidase inhibitor Inhibiting the activity of the viral neuraminidase enzyme, preventing budding from the host cell, viral replication, and infectivity Influenza viruses A [95, 96]\nApproved Penciclovir/ Acyclovir Nucleoside analog A synthetic acyclic guanine derivative, resulting in chain termination HSV, VZV [97]\nApproved, Investigational Ganciclovir Nucleoside analog Potent inhibitor of the Herpesvirus family including cytomegalovirus AIDS-associated cytomegalovirus infections [98]\nInvestigational Favipiravir (T-705) Nucleoside analog: Viral RNA polymerase inhibitor Acting on viral genetic copying to prevent its reproduction, without affecting host cellular RNA or DNA synthesis Ebola, influenza A(H1N1) [99–101]\nApproved, Investigational, Vet approved Nitazoxanide Antiprotozoal agent Modulating the survival, growth, and proliferation of a range of extracellular and intracellular protozoa, helminths, anaerobic and microaerophilic bacteria, viruses A wide range of viruses including human/animal coronaviruses [102–104]"}

    LitCovid-sentences

    {"project":"LitCovid-sentences","denotations":[{"id":"T167","span":{"begin":0,"end":70},"obj":"Sentence"},{"id":"T168","span":{"begin":71,"end":250},"obj":"Sentence"},{"id":"T169","span":{"begin":251,"end":418},"obj":"Sentence"},{"id":"T170","span":{"begin":419,"end":532},"obj":"Sentence"},{"id":"T171","span":{"begin":533,"end":575},"obj":"Sentence"},{"id":"T172","span":{"begin":576,"end":760},"obj":"Sentence"},{"id":"T173","span":{"begin":761,"end":943},"obj":"Sentence"},{"id":"T174","span":{"begin":944,"end":1150},"obj":"Sentence"},{"id":"T175","span":{"begin":1151,"end":1285},"obj":"Sentence"},{"id":"T176","span":{"begin":1286,"end":1458},"obj":"Sentence"},{"id":"T177","span":{"begin":1459,"end":1513},"obj":"Sentence"},{"id":"T178","span":{"begin":1514,"end":1692},"obj":"Sentence"},{"id":"T179","span":{"begin":1693,"end":2002},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Status Drugs Action mode Anti-infective mechanism Target diseases Ref.\nApproved Lopinavir/Ritonavir Protease inhibitors Inhibiting HIV-1 protease for protein cleavage, resulting in non-infectious, immature viral particles HIV/AIDS, SARS, MERS [83–85]\nApproved, Investigational, Vet approved Chloroquine 9-aminoquinolin Increasing endosomal pH, immunomodulating, autophagy inhibitors Malaria, autoimmune disease [79–82]\nExperimental Remdesivir (GS-5734) Nucleotide analogue prodrug Interfering with virus post-entry Ebola, SARS, MERS\n(A wide array of RNA viruses) [76, 88, 89]\nInvestigational Nafamostat Synthetic serine protease inhibitor Prevents membrane fusion by reducing the release of cathepsin B; anticoagulant activities Influenza, MERS, Ebola [90, 91]\nApproved Ribavirin Synthetic guanosine nucleoside Interfering with the synthesis of viral mRNA (a broad-spectrum activity against several RNA and DNA viruses) HCV, SARS, MERS [92–94]\nApproved Oseltamivir Neuraminidase inhibitor Inhibiting the activity of the viral neuraminidase enzyme, preventing budding from the host cell, viral replication, and infectivity Influenza viruses A [95, 96]\nApproved Penciclovir/ Acyclovir Nucleoside analog A synthetic acyclic guanine derivative, resulting in chain termination HSV, VZV [97]\nApproved, Investigational Ganciclovir Nucleoside analog Potent inhibitor of the Herpesvirus family including cytomegalovirus AIDS-associated cytomegalovirus infections [98]\nInvestigational Favipiravir (T-705) Nucleoside analog: Viral RNA polymerase inhibitor Acting on viral genetic copying to prevent its reproduction, without affecting host cellular RNA or DNA synthesis Ebola, influenza A(H1N1) [99–101]\nApproved, Investigational, Vet approved Nitazoxanide Antiprotozoal agent Modulating the survival, growth, and proliferation of a range of extracellular and intracellular protozoa, helminths, anaerobic and microaerophilic bacteria, viruses A wide range of viruses including human/animal coronaviruses [102–104]"}

    LitCovid-PD-HP

    {"project":"LitCovid-PD-HP","denotations":[{"id":"T51","span":{"begin":392,"end":410},"obj":"Phenotype"}],"attributes":[{"id":"A51","pred":"hp_id","subj":"T51","obj":"http://purl.obolibrary.org/obo/HP_0002960"}],"text":"Status Drugs Action mode Anti-infective mechanism Target diseases Ref.\nApproved Lopinavir/Ritonavir Protease inhibitors Inhibiting HIV-1 protease for protein cleavage, resulting in non-infectious, immature viral particles HIV/AIDS, SARS, MERS [83–85]\nApproved, Investigational, Vet approved Chloroquine 9-aminoquinolin Increasing endosomal pH, immunomodulating, autophagy inhibitors Malaria, autoimmune disease [79–82]\nExperimental Remdesivir (GS-5734) Nucleotide analogue prodrug Interfering with virus post-entry Ebola, SARS, MERS\n(A wide array of RNA viruses) [76, 88, 89]\nInvestigational Nafamostat Synthetic serine protease inhibitor Prevents membrane fusion by reducing the release of cathepsin B; anticoagulant activities Influenza, MERS, Ebola [90, 91]\nApproved Ribavirin Synthetic guanosine nucleoside Interfering with the synthesis of viral mRNA (a broad-spectrum activity against several RNA and DNA viruses) HCV, SARS, MERS [92–94]\nApproved Oseltamivir Neuraminidase inhibitor Inhibiting the activity of the viral neuraminidase enzyme, preventing budding from the host cell, viral replication, and infectivity Influenza viruses A [95, 96]\nApproved Penciclovir/ Acyclovir Nucleoside analog A synthetic acyclic guanine derivative, resulting in chain termination HSV, VZV [97]\nApproved, Investigational Ganciclovir Nucleoside analog Potent inhibitor of the Herpesvirus family including cytomegalovirus AIDS-associated cytomegalovirus infections [98]\nInvestigational Favipiravir (T-705) Nucleoside analog: Viral RNA polymerase inhibitor Acting on viral genetic copying to prevent its reproduction, without affecting host cellular RNA or DNA synthesis Ebola, influenza A(H1N1) [99–101]\nApproved, Investigational, Vet approved Nitazoxanide Antiprotozoal agent Modulating the survival, growth, and proliferation of a range of extracellular and intracellular protozoa, helminths, anaerobic and microaerophilic bacteria, viruses A wide range of viruses including human/animal coronaviruses [102–104]"}

    2_test

    {"project":"2_test","denotations":[{"id":"32169119-12662125-70132253","span":{"begin":244,"end":246},"obj":"12662125"},{"id":"32169119-31900204-70132253","span":{"begin":244,"end":246},"obj":"31900204"},{"id":"32169119-14985565-70132253","span":{"begin":244,"end":246},"obj":"14985565"},{"id":"32169119-14592603-70132254","span":{"begin":412,"end":414},"obj":"14592603"},{"id":"32169119-16115318-70132254","span":{"begin":412,"end":414},"obj":"16115318"},{"id":"32169119-25727221-70132254","span":{"begin":412,"end":414},"obj":"25727221"},{"id":"32169119-32020029-70132254","span":{"begin":412,"end":414},"obj":"32020029"},{"id":"32169119-29511076-70132255","span":{"begin":564,"end":566},"obj":"29511076"},{"id":"32169119-30987343-70132256","span":{"begin":568,"end":570},"obj":"30987343"},{"id":"32169119-31142680-70132257","span":{"begin":572,"end":574},"obj":"31142680"},{"id":"32169119-18220789-70132258","span":{"begin":753,"end":755},"obj":"18220789"},{"id":"32169119-26346967-70132259","span":{"begin":757,"end":759},"obj":"26346967"},{"id":"32169119-30215672-70132260","span":{"begin":937,"end":939},"obj":"30215672"},{"id":"32169119-15018130-70132260","span":{"begin":937,"end":939},"obj":"15018130"},{"id":"32169119-24811411-70132261","span":{"begin":1147,"end":1149},"obj":"24811411"},{"id":"32169119-29896665-70132262","span":{"begin":1282,"end":1284},"obj":"29896665"},{"id":"32169119-29678260-70132263","span":{"begin":1455,"end":1457},"obj":"29678260"},{"id":"32169119-24084488-70132264","span":{"begin":1685,"end":1687},"obj":"24084488"},{"id":"32169119-25108173-70132265","span":{"begin":1994,"end":1997},"obj":"25108173"},{"id":"32169119-25451075-70132265","span":{"begin":1994,"end":1997},"obj":"25451075"},{"id":"32169119-27095301-70132265","span":{"begin":1994,"end":1997},"obj":"27095301"}],"text":"Status Drugs Action mode Anti-infective mechanism Target diseases Ref.\nApproved Lopinavir/Ritonavir Protease inhibitors Inhibiting HIV-1 protease for protein cleavage, resulting in non-infectious, immature viral particles HIV/AIDS, SARS, MERS [83–85]\nApproved, Investigational, Vet approved Chloroquine 9-aminoquinolin Increasing endosomal pH, immunomodulating, autophagy inhibitors Malaria, autoimmune disease [79–82]\nExperimental Remdesivir (GS-5734) Nucleotide analogue prodrug Interfering with virus post-entry Ebola, SARS, MERS\n(A wide array of RNA viruses) [76, 88, 89]\nInvestigational Nafamostat Synthetic serine protease inhibitor Prevents membrane fusion by reducing the release of cathepsin B; anticoagulant activities Influenza, MERS, Ebola [90, 91]\nApproved Ribavirin Synthetic guanosine nucleoside Interfering with the synthesis of viral mRNA (a broad-spectrum activity against several RNA and DNA viruses) HCV, SARS, MERS [92–94]\nApproved Oseltamivir Neuraminidase inhibitor Inhibiting the activity of the viral neuraminidase enzyme, preventing budding from the host cell, viral replication, and infectivity Influenza viruses A [95, 96]\nApproved Penciclovir/ Acyclovir Nucleoside analog A synthetic acyclic guanine derivative, resulting in chain termination HSV, VZV [97]\nApproved, Investigational Ganciclovir Nucleoside analog Potent inhibitor of the Herpesvirus family including cytomegalovirus AIDS-associated cytomegalovirus infections [98]\nInvestigational Favipiravir (T-705) Nucleoside analog: Viral RNA polymerase inhibitor Acting on viral genetic copying to prevent its reproduction, without affecting host cellular RNA or DNA synthesis Ebola, influenza A(H1N1) [99–101]\nApproved, Investigational, Vet approved Nitazoxanide Antiprotozoal agent Modulating the survival, growth, and proliferation of a range of extracellular and intracellular protozoa, helminths, anaerobic and microaerophilic bacteria, viruses A wide range of viruses including human/animal coronaviruses [102–104]"}